Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9.
Clinical chemistry, 64(3): 489-491 PMID 29490999 DOI 10.1373/clinchem.2017.278317
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.